The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(4-butoxyphenyl)penta-2,4-dienehydrazide ID: ALA5202813
PubChem CID: 168293426
Max Phase: Preclinical
Molecular Formula: C15H20N2O2
Molecular Weight: 260.34
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCOc1ccc(/C=C/C=C/C(=O)NN)cc1
Standard InChI: InChI=1S/C15H20N2O2/c1-2-3-12-19-14-10-8-13(9-11-14)6-4-5-7-15(18)17-16/h4-11H,2-3,12,16H2,1H3,(H,17,18)/b6-4+,7-5+
Standard InChI Key: JOISJOBROIPPRH-YDFGWWAZSA-N
Molfile:
RDKit 2D
19 19 0 0 0 0 0 0 0 0999 V2000
-5.0005 -1.2364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2861 -0.8239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5716 -1.2364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8572 -0.8239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1427 -1.2364 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4282 -0.8239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4282 -0.0030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7181 0.4133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0005 -0.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7138 0.4116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4282 -0.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1427 0.4116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8572 -0.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5716 0.4116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2861 -0.0008 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0005 0.4116 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5716 1.2365 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0005 -0.8259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7136 -1.2365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 3 1 0
5 4 1 0
6 5 1 0
7 6 1 0
8 7 2 0
9 8 1 0
10 9 1 0
11 10 2 0
12 11 1 0
12 13 2 0
13 14 1 0
14 15 1 0
15 16 1 0
14 17 2 0
18 9 2 0
19 18 1 0
6 19 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 260.34Molecular Weight (Monoisotopic): 260.1525AlogP: 2.42#Rotatable Bonds: 7Polar Surface Area: 64.35Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.72CX Basic pKa: 3.29CX LogP: 2.73CX LogD: 2.73Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.20Np Likeness Score: -0.15
References 1. Mavrikaki V, Pagonis A, Poncin I, Mallick I, Canaan S, Magrioti V, Cavalier JF.. (2022) Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives., 64 [PMID:35307568 ] [10.1016/j.bmcl.2022.128692 ]